DrugPatentWatch Database Preview
Patent: 4,767,709
» See Plans and Pricing
Summary for Patent: 4,767,709
| Title: | Growth-related hormones |
| Abstract: | Proliferin, a growth-related hormone of the prolactin-growth hormone family is provided, as well as DNA molecules encoding proliferin and methods of expressing the DNA molecules in vivo. Methods of probing for proliferin encoding DNA are also provided. |
| Inventor(s): | Nathans; Daniel (Baltimore, MD), Linzer; Daniel I. H. (Baltimore, MD) |
| Assignee: | The Johns Hopkins University (Baltimore, MD) |
| Application Number: | 06/625,499 |
| Patent Claims: | see list of patent claims |
Details for Patent 4,767,709
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | The Johns Hopkins University (Baltimore, MD) | 2039-02-26 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | The Johns Hopkins University (Baltimore, MD) | 2039-02-26 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | The Johns Hopkins University (Baltimore, MD) | 2039-02-26 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 4,767,709
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 8600338 | Start Trial |
| Japan | S61502514 | Start Trial |
| European Patent Office | 0190163 | Start Trial |
| Australia | 4492085 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
